Affiliation:
1. Department of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio
Abstract
AbstractThe success of any clinical trial relies heavily on patient recruitment and retention. The purpose of this study was to review screening and enrollment metrics for orthopaedic clinical trials, comparing different patient populations to determine common challenges to recruitment and differences in rates of enrollment. Screening logs and study trackers were manually reviewed for four clinical trials at a single academic institution and included randomized controlled trials (RCTs) and an observational study. Data extracted from these documents included the number of patients screened, number excluded and reasons for exclusion, number enrolled, number of withdrawn and reason. Of the four trials reviewed, the point-of-care diagnostic test had the highest number of patients excluded and the lowest patient refusal rate. Refusal rates were highest in the venous thromboembolism prophylaxis study and enrollment rates were the lowest in the RCT of drug treatments and the highest rate in the observational study. The success of the trial relies on the ability to recruit patients and factors need to be considered when recruiting participants including sample size requirements and inclusion and exclusion criteria. These data provide some insights into the patient recruitment experience at our institution with different patient populations and study types, highlighting key points to be aware of when planning for an orthopaedic clinical trial.
Subject
Orthopedics and Sports Medicine,Surgery
Reference24 articles.
1. Factors influencing recruitment and retention of participants in clinical studies conducted at a tertiary referral center: A five-year audit;D Bose;Perspect Clin Res,2020
2. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review;D B Fogel;Contemp Clin Trials Commun,2018
3. Early termination of randomized clinical trials in orthopaedics;N Piuzzi;Surg Technol Int,2017
4. Screen failure rates in contemporary randomized clinical phase II/III therapeutic trials in genitourinary malignancies;S E Wong;Clin Genitourin Cancer,2017